Trial Profile
An Open-label, Randomized, Three-period Crossover Trial in Healthy HIV-negative Women to Assess the Drug-drug Interaction Between Dapivirine Vaginal Ring-004 and Miconazole Nitrate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary) ; Miconazole (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- Sponsors International Partnership for Microbicides
- 01 Oct 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov record.
- 26 Dec 2012 New trial record